Sign in

Daniel Hoces

@dhoces.bsky.social
284 followers 162 following 14 posts

Postdoc @Stanford. Engineering immune cells to enhance vaccine responses. Ph.D. @ETH_en | M.D. @CayetanoHeredia 🇵🇪 🇨🇭

PostsRepliesMedia
Reposted by Daniel Hoces
Nature Reviews Immunology @natrevimmunol.nature.com · 26/08/2026
ICYMI: Beyond the quick win: rebuilding the foundations of cancer immunotherapy
dlvr.it
Beyond the quick win: rebuilding the foundations of cancer immunotherapy
Nature Reviews Immunology, Published online: 25 August 2026; doi:10.1038/s41577-026-01352-9Checkpoint inhibitors, CAR T cells and bispecific T cell engagers have demonstrated the transformative potential of cancer immunotherapy. However, progress has slowed as efforts have focused on replicating PD-(L)1 blockade successes, highlighting the need for deeper understanding of human cancer immunity.
011
Reposted by Daniel Hoces
Waggoner Lab @labwaggoner.bsky.social · 19/08/2026
Synthetic transcription factors designed by domain recombination enhance CAR T cell antitumor function @cellcellpress.bsky.social www.cell.com/cell/fulltex... @stanforduniversity.bsky.social #Roth #Satpathy
011
Reposted by Daniel Hoces
Caetano Reis e Sousa @reisesousalab.bsky.social · 19/08/2026
Hope you enjoy this short piece, which came out yesterday. Some thoughts I’ve been musing on for a while about why adaptive immunity evolved. Read it for free at rdcu.be/fAO5P
rdcu.be
Why adaptive immunity?
Nature Reviews Immunology - Adaptive immunity is indispensable to vertebrates, yet most living organisms defend themselves perfectly well without it. Here, I ask why somatically diversified antigen...
34416
Reposted by Daniel Hoces
Katia Faliti @katyely.bsky.social · 18/05/2026
Pre-print alert 📰 🚨I’m very grateful and excited to share our new study : "Defective B cell tolerance in SLE lymph nodes underpins VH4-34 "clonal damnation" and PD-1+TOX+ autoreactive B cells expansion". doi: doi.org/10.64898/202... lnkd.in/eJwMTUEt
051
Reposted by Daniel Hoces
Daniela Latorre @lablatorre.bsky.social · 20/04/2026
🔬 We’re hiring again! Looking for 1 #PhD student to join the #MSCA-DN TRANSCEND network 🧬 Project on unconventional #Tcells in #MultipleSclerosis with research exchanges in 🇩🇰 Klaus Eyer’s lab, Aarhus 🇳🇴 Victor Greiff’s lab, Oslo ⏳ Deadline: May 10 👉 euraxess.ec.europa.eu/jobs/403235
euraxess.ec.europa.eu
Open Call for 1 PhD Position at Università Vita-Salute San Raffaele in the frame of the MSCA Doctoral Network
Multiple sclerosis (MS), is an autoimmune disease of the central nervous system (CNS), characterized by demyelination and neuronal loss, along with immune cell brain infiltration and inflammation.
073
Reposted by Daniel Hoces
Michela Locci @michelalocci.bsky.social · 16/12/2025
I am excited to share that our work, in which we have dissected the signals driven by the nucleoside-modified mRNA and LNP components of mRNA vaccines that regulate germinal center (GC) responses, is now published in Cell! www.cell.com/cell/fulltex...
cell.com
Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses
This study dissects the individual contributions of the different components of mRNA vaccines to immune responses. Nucleoside-modified mRNA promotes the production of type I interferons that act on de...
54919
Daniel Hoces @dhoces.bsky.social · 10/11/2025
Emma is an incredible mentor and scientist! Plus, Switzerland is a powerhouse of high-quality science. Don’t doubt to apply to this position.
010
Reposted by Daniel Hoces
Emma Slack @mucosalimmunology.bsky.social · 09/11/2025
1 week left to apply for a postdoc position in beautiful Switzerland doing awesome mucosal immunology. See below for details! Please re-post to spread the word!
065
Reposted by Daniel Hoces
Emma Slack @mucosalimmunology.bsky.social · 29/10/2025
We are hiring! 🧫 🧬 🚀 Three PhD studentships with start dates in 2026 available in the Molecular Mucosal Immunology lab at the Botnar Institute of Immune Engineering, Basel, Switzerland. See here for details (Deadline: 7th November 2025): join.com/companies/im...
join.com
Botnar Institute of Immune Engineering - BIIE (Zürich): Doctoral studentships, Molecular Mucosal Immunology Group
Botnar Institute of Immune Engineering - BIIE has a job opening for Doctoral studentships, Molecular Mucosal Immunology Group in Zürich (published: 29.10.2025). Apply now or check the other available...
01012
Reposted by Daniel Hoces
Possu Huang Lab @possuhuanglab.bsky.social · 09/10/2025
Introducing SLAE, our new framework to represent all-atom protein structures with residue local chemical environment tokens! SLAE reasons over atomic interactions to recover structures and residue pairwise energetics, yielding a generalizable, physics-informed latent space. (1/8)
171
Reposted by Daniel Hoces
bioRxiv Immunology @biorxiv-immuno.bsky.social · 03/09/2025
Excitability as a Design Principle in the Immune System www.biorxiv.org/content/10.1101/202…
021
Reposted by Daniel Hoces
bioRxiv Immunology @biorxiv-immuno.bsky.social · 03/09/2025
LCK deficiency in CD8 T cells leads to reduced proliferation and increased effector T-cell formation in mice www.biorxiv.org/content/10.1101/202…
002
Reposted by Daniel Hoces
Viktoria Flore @viktoriaflore.bsky.social · 07/08/2025
Did you ever wonder what insights hide in the multiplets that are usually discarded in flow cytometry? 🫧 Find out in the first publication of my PhD, now out in Nature Methods! www.nature.com/articles/s41... (1/4)
nature.com
Ultra-high-scale cytometry-based cellular interaction mapping - Nature Methods
Interact-omics, a high-throughput cytometry-based framework, resolves the cellular interaction landscape.
33817
Reposted by Daniel Hoces
Omer Dushek @tcell.bsky.social · 31/05/2025
Our new review article led by Jordan Kramer: Platforms for studying cell–cell recognition by immune cells onlinelibrary.wiley.com/doi/10.1111/...
2196
Reposted by Daniel Hoces
Paul Francois @pfrancois.bsky.social · 14/04/2025
As promised, a 'skeet' -orial on our paper published last week !
1289
Reposted by Daniel Hoces
Jane Yinghui Huang @janehuang.bsky.social · 28/03/2025
Excited to share my graduate work from the @ejohnwherry.bsky.social lab on the molecular mechanisms locking in the differentiation fate of exhausted CD8 T cells (Tex), published earlier this month in @science.org immunology. Main findings below! www.science.org/doi/10.1126/...
science.org
Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate
TOX safeguards exhaustion biology in established Tex cells and restrains fate conversion to Teff cells.
13517
Reposted by Daniel Hoces
Sarah Ross @sarahhross.bsky.social · 14/03/2025
ICYMI by First release - now in print @science.org Identification of APCs in the gut that promote Treg differentiation and how tolerance to food antigens is influenced by helminth infection. buff.ly/3DjNQ1e By @cicacanesso.bsky.social @danmucida.bsky.social @victora.bsky.social et al
25817
Reposted by Daniel Hoces
Steve Turner @sjturn.bsky.social · 01/03/2025
Our paper is finally out in @immunolcellbiol.bsky.social, think that transcription factor expression is all that? Well not if the genome is not prepared in a way to allow binding: here is a short 🧵1/
1184
Reposted by Daniel Hoces
Seth Bannon @sethbannon.bsky.social · 17/02/2025
1/ Ever wonder how a clearly brilliant person – someone great a math and engineering and company building – can display shockingly unintelligent thinking when it comes to politics? Neuroscience has the answer!
232
Reposted by Daniel Hoces
Emma Slack @mucosalimmunology.bsky.social · 10/02/2025
Two weeks left to apply for a postdoc position with the Slack group! Please spread the word!
12224
Reposted by Daniel Hoces
Omer Dushek @tcell.bsky.social · 16/01/2025
Our new work! The 3D affinities of the OT-I TCR to foreign and self-antigens predict their 2D affinities and reveal imperfect antigen discrimination www.biorxiv.org/content/10.1...
2184
Reposted by Daniel Hoces
Daniel Utzschneider @danielutzschneider.bsky.social · 09/01/2025
Two studies published in @nature.com today showing that Tpex-like cells develop independent from acute or chronic infection #Tpex www.nature.com/articles/s41...
nature.com
Precursors of exhausted T cells are preemptively formed in acute infection - Nature
Nature - Precursors of exhausted T cells are preemptively formed in acute infection
184
Reposted by Daniel Hoces
Omer Dushek @tcell.bsky.social · 04/01/2025
Our work led by Anna Huhn is now published! The molecular reach of antibodies crucially underpins their viral neutralisation capacity lnkd.in/epe8YZPm Thank you to the reviewers for constructive feedback!
184
Reposted by Daniel Hoces
The Kueh lab @kuehlab.bsky.social · 03/01/2025
Happy New Year! Excited about our new study on a timed epigenetic switch controlling T cell and ILC lineage decisions in the thymus! In a nutshell: timing is everything. The study was led by the fantastic @nickpease.bsky.social. A thread: (1/n) doi.org/10.1242/dev....
doi.org
A timed epigenetic switch balances T and ILC lineage proportions in the thymus
Highlighted Article: Delayed activation of the T-cell lineage commitment regulator Bcl11b in mouse thymic progenitors due to distal enhancer deletion reduces T-cell output and increases Zbtb16-driven ...
12310
Reposted by Daniel Hoces
Enfu Hui @enfuhui.bsky.social · 04/01/2025
Thrilled to share our @sciimmunology.bsky.social paper! We report that rodent PD-1 is weaker than human PD-1 (reduced ligand binding & signaling) & lacks a conserved vertebrate motif. Humanizing mouse PD-1 disrupts T cell anti-tumor responses, raising many questions. science.org/doi/10.1126/...
23816
Reposted by Daniel Hoces
Waggoner Lab @labwaggoner.bsky.social · 02/01/2025
Prior antigen experience of CAR T cells determines functional attributes and amenability to transcription factor-mediated functional enhancement www.nature.com/articles/s41... @koledegolier.bsky.social www.nature.com/articles/s41...
062
Reposted by Daniel Hoces
Rafael Irizarry @rafalab.bsky.social · 23/12/2024
Biologist, stop putting UMAP plots in papers! Blogpost here: simplystatistics.org/posts/2024-1...
simplystatistics.org
Simply Statistics: Biologists, stop putting UMAP plots in your papers
UMAP is a powerful tool for exploratory data analysis, but without a clear understanding of how it works, it can easily lead to confusion and misinterpretation.
2024068
Reposted by Daniel Hoces
Thiago Carvalho @cyrilpedia.bsky.social · 22/12/2024
'The TME of Long Term Survival cases was distinguished by coinfiltration of T cells, B cells & plasma cells, along with upregulation of the PD-1/PD-L1 pathway. Remarkably, these prognostic associations were almost entirely restricted to tumors with high-epithelial content & the C4/DIF mol. subtype'
jci.org
JCI - Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
012
Reposted by Daniel Hoces
Thiago Carvalho @cyrilpedia.bsky.social · 21/12/2024
"(...) reinforcing 41BB costimulation on the day of vaccination did not result in a substantial improvement in vaccine responses. However, reinforcing 41BB costimulation on day 4 after vaccination, when 41BB expression levels were highest, resulted in a profound improvement in CD8+ T cell responses"
jci.org
JCI - Delayed reinforcement of costimulation improves the efficacy of mRNA vaccines in mice
193
Reposted by Daniel Hoces
ACIR @acir-org.bsky.social · 21/12/2024
🖐️ Hi Mam! - A superantigen (MAM) goes to the head of the class (II) to find alternatives to TCRs for specific peptide:MHC binders doi.org/10.1038/s415...
032
Daniel Hoces @dhoces.bsky.social · 17/12/2024
This is a clever way to use synthetic biology: taking a toxin that overactivate the immune system (superantigen), rationally modify its core components and transform it into a platform of immunotherapy agents. Congratulations to @haotiandu.bsky.social and @possuhuanglab.bsky.social on the 2 papers!
162
Reposted by Daniel Hoces
Possu Huang Lab @possuhuanglab.bsky.social · 17/12/2024
1/ In two back-to-back papers, we present our de novo TRACeR platform for targeting MHC-I and MHC-II antigens TRACeR for MHC-I: go.nature.com/4gcLzn5 TRACeR for MHC-II: go.nature.com/4gj5OQk
29129
Reposted by Daniel Hoces
Sarah Ross @sarahhross.bsky.social · 13/12/2024
Out this week @science.org by first release: Specific combinations of nutrients and metabolic enzymes determine T cell differentiation via loci-specific histone acetylations. buff.ly/4gvqKTz From Shixin Ma, Sue Kaech @tcellogic.bsky.social and colleagues #Immunology #immunometabolism
1315
Reposted by Daniel Hoces
Djenet Bousbaine @djenetbousbaine.bsky.social · 12/12/2024
Check out our last pub. from @mfgrp.bsky.social al lab! We discovered that skin commensal microbes induce systemic and local B cell responses upon colonization and took advantage of this knowledge to create topical vaccines using engineered skin microbes. Please read the thread for details.
3267
Reposted by Daniel Hoces
Michael Fischbach @mfgrp.bsky.social · 11/12/2024
Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent antibody response against a pathogen. Could lead to topical vaccines that are applied in a cream. @djenetbousbaine.bsky.social led the charge... @natureportfolio.bsky.social 1/55
23693294
Reposted by Daniel Hoces
Paul Rennert @pdrworld.bsky.social · 11/12/2024
In #biotech #celltherapy news, in vivo CAR T company #Esobiotec has dosed Patient 1 with their proprietary lentiviral therapy for rrMM finance.yahoo.com/news/esobiot... joining the top tier with Interius, Umoja etc. Disclosure: I'm an independent Board Member and wicked proud of the team.
finance.yahoo.com
EsoBiotec Begins Clinical Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma
ESO-T01 is the first in vivo BCMA CAR-T candidate to reach the clinical stage Early clinical data are expected in second half of 2025 MONT-SAINT-GUIBERT, Belgium, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Eso...
011
Reposted by Daniel Hoces
Michael Jain @michaeldjain.bsky.social · 06/12/2024
Fascinating study where they label CAR T cells and follow their trafficking in patients! Immediate biodistribution is to the liver and spleen, and they can see whether the Car goes into extramedullary masses. What explains differences between patients?
164
Reposted by Daniel Hoces
Dominic Grün @dominicgrun.bsky.social · 06/12/2024
NiCo is out! Our new algorithm for spatial transcriptomics data analysis predicts the crosstalk of cell types co-localized in tissue niches and sheds light on signalling mediators and downstream effects of cell-cell interactions by inferring covarying gene programs. www.nature.com/articles/s41...
17516
Daniel Hoces @dhoces.bsky.social · 06/12/2024
Engineering cells as “live-drugs” is a promising therapeutic strategy, with applications that go beyond cancer. Congrats to Nishith and Milos! Great to see your work published!
020
Reposted by Daniel Hoces
Jeff Mold @jeffmold.bsky.social · 05/12/2024
Wowza! Lim lab drops bombs in 2s! www.science.org/doi/10.1126/... www.science.org/doi/10.1126/...
science.org
Programming tissue-sensing T cells that deliver therapies to the brain
To engineer cells that can specifically target the central nervous system (CNS), we identified extracellular CNS-specific antigens, including components of the CNS extracellular matrix and surface mol...
24113
Daniel Hoces @dhoces.bsky.social · 05/12/2024
After spending a week learning scRNAseq at SCALE @mskcancercenter.bsky.social, I think this thread below is a good reminder of: 1) the key importance of QC in sc data interpretation and 2) how QC is an iterative process that can be updated when new tools are available.
020
Reposted by Daniel Hoces
Alice Ting @aliceyting.bsky.social · 04/12/2024
Could one envision a synthetic receptor technology that is fully programmable, able to detect diverse extracellular antigens – both soluble and cell-attached – and convert that recognition into a wide range of intracellular responses, from gene expression and real-time fluorescence to modulation..
33434138
Reposted by Daniel Hoces
Tomàs Montserrat Ayuso @tmontsay.bsky.social · 03/12/2024
Not checking nuclear markers like MALAT1 or intronic reads in your scRNA-seq data?🚨 We show their power to flag low-quality cells—even in top public datasets. It’s time to prioritize better QC for cleaner, more reliable genomics research! Read more: bmcgenomics.biomedcentral.com/articles/10.... 1/8
bmcgenomics.biomedcentral.com
High content of nuclei-free low-quality cells in reference single-cell atlases: a call for more stringent quality control using nuclear fraction - BMC Genomics
The advent of droplet-based single-cell RNA-sequencing (scRNA-seq) has dramatically increased data throughput, enabling the release of a diverse array of tissue cell atlases to the public. However, we...
4244126
Reposted by Daniel Hoces
Anshul Kundaje @anshulkundaje.bsky.social · 04/12/2024
This is really horrific. These single cell reference atlases are widely used as is to train all kinds of models! This is one of the reasons I've constantly harping about uniform reprocessing & extremely careful QC of large atlases. 1/
914441
Reposted by Daniel Hoces
Itai Yanai @itaiyanai.bsky.social · 03/12/2024
What were the most inspiring 2024 discoveries in cancer? Cancer Discovery asked me, Katherine Aird, Aadel Chaudhuri, Jennifer Guerriero, Shiri Gur-Cohen, Benjamin Izar, Brittany Jenkins, Delphine Merino, Alejo Rodriguez-Fraticelli & Shensi Shen, & here's what we said aacrjournals.org/cancerdiscov...
18633
Reposted by Daniel Hoces
Thiago Carvalho @cyrilpedia.bsky.social · 02/12/2024
"The identification of stem-like CD4+ T cells that replenished the autoimmune lesion mirrors earlier findings of islet-specific stem-like CD8+ T cells in both mice and humans with diabetes" #Immunology #Autoimmunity www.cell.com/trends/immun...
cell.com
How do autoimmune CD4+ T cells handle exhaustion?
Chronic antigen exposure is frequently associated with T cell exhaustion. In a recent study, Aljobaily et al. show that pancreatic islet-infiltrating CD4+ T cells in mouse autoimmune diabetes may circ...
1244
Reposted by Daniel Hoces
Jeff Mold @jeffmold.bsky.social · 02/12/2024
In lots of cell atlases the immune system seems to be the guest of honour - getting premier spots in the main figures (not the extended, or extended extended figures) - I have a theory about this...
1142
Reposted by Daniel Hoces
Seth Thomas Scanlon @immunoeditor.bsky.social · 29/11/2024
Now in #Science #Immunology: Ziang Zhu, Tuoqi Wu, Chen Yao et al at UT Southwestern show that #NRF2 suppression mediated by the #redox sensor #KEAP1 is required for optimal expansion of #CD8 #TCells during chronic antigen exposure!
science.org
The redox sensor KEAP1 facilitates adaptation of T cells to chronic antigen stimulation by preventing hyperactivation
KEAP1 promotes persistent T cell immunity and a stem-like T cell response during chronic antigen stimulation by repressing NRF2.
02811
Reposted by Daniel Hoces
Waggoner Lab @labwaggoner.bsky.social · 29/11/2024
IL-2 acts intrinsically on B cells to trigger a “vanguard” metabolic shift that activates mTOR, reprograms B cell metabolism, and drives their differentiation into extra-follicular plasma cell, diverting them from germinal center selection www.cell.com/immunity/ful...
3269
Reposted by Daniel Hoces
Waggoner Lab @labwaggoner.bsky.social · 28/11/2024
Cancer cells blunt monocyte IFN while increasing PGE2 to inhibit T cell immunity @obenaufa.bsky.social @aelewaut.bsky.social @guillemxtivill.bsky.social www.nature.com/articles/s41...
0194